Tag: Mindset Pharma - Psychedelic Alpha

Introducing Pα+: learn more and subscribe today.

Read more about the article BREAKING: Big Pharma Company Otsuka to Acquire Mindset Pharma for CAD $80m

BREAKING: Big Pharma Company Otsuka to Acquire Mindset Pharma for CAD $80m

Post published:August 31, 2023
Post category:News

Read more about the article Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Mindset Pharma to Participate in the Sequire Cannabis & Psychedelics Conference on Wednesday, April 5, 2023

Post published:April 3, 2023
Post category:Press Release

Read more about the article Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics

Mindset Pharma CEO, James Lanthier, Issues Letter to Shareholders Discussing Expansion of Drug Discovery Efforts into Novel Non-Hallucinogenic Therapeutics

Post published:March 28, 2023
Post category:Press Release

Read more about the article Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences

Mindset Pharma To Defend Against Lawsuit Filed By Reunion Neurosciences

Post published:March 14, 2023
Post category:Press Release

Read more about the article Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales Partnership

Mindset Pharma and PharmAla Complete First Sale of Pharmaceutical Grade Psilocybin Into Growing Australian Market via Sales Partnership

Post published:March 6, 2023
Post category:Press Release

Read more about the article Mindset Pharma Receives Another Allowance from USPTO for Patent Application Expanding Composition of Matter for Family 1 Psilocybin Analogs

Mindset Pharma Receives Another Allowance from USPTO for Patent Application Expanding Composition of Matter for Family 1 Psilocybin Analogs

Post published:February 2, 2023
Post category:Press Release

Read more about the article Mindset Pharma to Participate in Upcoming Conferences in December 2022

Mindset Pharma to Participate in Upcoming Conferences in December 2022

Post published:December 6, 2022
Post category:Press Release

Read more about the article Mindset Pharma Announces Poster Presentations at Two Upcoming Scientific Conferences

Mindset Pharma Announces Poster Presentations at Two Upcoming Scientific Conferences

Post published:October 28, 2022
Post category:Press Release

Read more about the article Mindset Pharma Selects Lead Clinical Candidates From “Family 2” of its Next Generation Psychedelic Drug Portfolio

Mindset Pharma Selects Lead Clinical Candidates From “Family 2” of its Next Generation Psychedelic Drug Portfolio

Post published:October 6, 2022
Post category:Press Release

Read more about the article Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Mindset Pharma Provides Strategic Intellectual Property License to Cybin

Post published:September 28, 2022
Post category:Press Release

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Newsletter

Insights and interviews delivered to your inbox. No spam, just valuable information.